Disclosures for "GLP-1 Receptor Agonists vs. SGLT2 Inhibitors and the Risk of Alzheimer’s Disease in Type 2 Diabetes: A Systematic Review and Meta-Analysis"
-
Dr. Silva has nothing to disclose.
-
Dr. Moura has nothing to disclose.
-
Miss Valverde has nothing to disclose.
-
Prof. P da Silva has nothing to disclose.
-
Miss Diniz Guerra Braz has nothing to disclose.
-
Mr. da Silva has nothing to disclose.
-
Mr. Aguiar has nothing to disclose.
-
Dr. Volta has nothing to disclose.
-
Miss Oliveira has nothing to disclose.
-
Mr. Andreão has nothing to disclose.
-
Dr. Rodrigues Cal has nothing to disclose.
-
Dr. Haddad Santos has nothing to disclose.